{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:01:39Z","timestamp":1784552499926,"version":"3.55.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Postdoctoral Research Project Startup Fund of Fujian Medical University Union Hospital","award":["2023XH023"],"award-info":[{"award-number":["2023XH023"]}]},{"name":"the Startup Fund for Scientific Research of Fujian Medical University","award":["2024QH2020"],"award-info":[{"award-number":["2024QH2020"]}]},{"name":"the Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2023Y9008"],"award-info":[{"award-number":["2023Y9008"]}]},{"name":"the Major Special Project of Fujian Provincial Health Technology Project","award":["2024ZD01002"],"award-info":[{"award-number":["2024ZD01002"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U23A20423"],"award-info":[{"award-number":["U23A20423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Clinical Research Center for Precision Diagnosis and Treatment of Neurological Diseases of Fujian Province","award":["2022Y2005"],"award-info":[{"award-number":["2022Y2005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04552-6","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:06:52Z","timestamp":1779509212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineered neuronal exosomes mediate \u03b1-synuclein clearance to ameliorate Parkinson\u2019s disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Lufei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zucheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"4552_CR1","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025;388:e080952.","journal-title":"BMJ"},{"key":"4552_CR2","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1038\/s41467-024-46007-2","volume":"15","author":"F Giamogante","year":"2024","unstructured":"Giamogante F, Barazzuol L, Maiorca F, Poggio E, Esposito A, Masato A, Napolitano G, Vagnoni A, Cali T, Brini M. A SPLICS reporter reveals [Formula: see text]-synuclein regulation of lysosome-mitochondria contacts which affects TFEB nuclear translocation. Nat Commun. 2024;15:1516.","journal-title":"Nat Commun"},{"key":"4552_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14:176.","journal-title":"Cell Death Dis"},{"key":"4552_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1523\/JNEUROSCI.2507-13.2014","volume":"34","author":"C Guardia-Laguarta","year":"2014","unstructured":"Guardia-Laguarta C, Area-Gomez E, Rub C, Liu Y, Magrane J, Becker D, Voos W, Schon EA, Przedborski S. alpha-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci. 2014;34:249\u201359.","journal-title":"J Neurosci"},{"key":"4552_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bph.15684","volume":"179","author":"ME Haque","year":"2022","unstructured":"Haque ME, Akther M, Azam S, Kim IS, Lin Y, Lee YH, Choi DK. Targeting alpha-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson\u2019s disease. Br J Pharmacol. 2022;179:23\u201345.","journal-title":"Br J Pharmacol"},{"key":"4552_CR6","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","volume":"13","author":"LD Bernal-Conde","year":"2019","unstructured":"Bernal-Conde LD, Ramos-Acevedo R, Reyes-Hernandez MA, Balbuena-Olvera AJ, Morales-Moreno ID, Arguero-Sanchez R, Schule B, Guerra-Crespo M. Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles. Front Neurosci. 2019;13:1399.","journal-title":"Front Neurosci"},{"key":"4552_CR7","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/s41593-024-01775-4","volume":"27","author":"A Bayati","year":"2024","unstructured":"Bayati A, Ayoubi R, Aguila A, Zorca CE, Deyab G, Han C, Recinto SJ, Nguyen-Renou E, Rocha C, Maussion G, et al. Modeling Parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to alpha-synuclein fibrils and proinflammatory cytokines. Nat Neurosci. 2024;27:2401\u201316.","journal-title":"Nat Neurosci"},{"key":"4552_CR8","first-page":"20220115","volume":"3","author":"H Peng","year":"2023","unstructured":"Peng H, Yao F, Zhao J, Zhang W, Chen L, Wang X, Yang P, Tang J, Chi Y. Unraveling mitochondria-targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Explor (Beijing). 2023;3:20220115.","journal-title":"Explor (Beijing)"},{"key":"4552_CR9","doi-asserted-by":"publisher","first-page":"e2403450121","DOI":"10.1073\/pnas.2403450121","volume":"121","author":"CR Coleman","year":"2024","unstructured":"Coleman CR, Pallos J, Arreola-Bustos A, Wang L, Raftery D, Promislow DEL, Martin I. Natural variation in age-related dopamine neuron degeneration is glutathione dependent and linked to life span. Proc Natl Acad Sci U S A. 2024;121:e2403450121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4552_CR10","first-page":"20230063","volume":"4","author":"K Qian","year":"2024","unstructured":"Qian K, Gao S, Jiang Z, Ding Q, Cheng Z. Recent advances in mitochondria-targeting theranostic agents. Explor (Beijing). 2024;4:20230063.","journal-title":"Explor (Beijing)"},{"key":"4552_CR11","doi-asserted-by":"publisher","first-page":"17203","DOI":"10.3390\/ijms242417203","volume":"24","author":"T Liu","year":"2023","unstructured":"Liu T, Wu H, Wei J. The Construction and Validation of a Novel Ferroptosis-Related Gene Signature in Parkinson\u2019s Disease. Int J Mol Sci. 2023;24:17203.","journal-title":"Int J Mol Sci"},{"key":"4552_CR12","doi-asserted-by":"publisher","first-page":"105543","DOI":"10.1016\/j.nbd.2021.105543","volume":"161","author":"E Nordstrom","year":"2021","unstructured":"Nordstrom E, Eriksson F, Sigvardson J, Johannesson M, Kasrayan A, Jones-Kostalla M, Appelkvist P, Soderberg L, Nygren P, Blom M, et al. ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson\u2019s disease. Neurobiol Dis. 2021;161:105543.","journal-title":"Neurobiol Dis"},{"key":"4552_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, et al. Trial of Cinpanemab in Early Parkinson\u2019s Disease. N Engl J Med. 2022;387:408\u201320.","journal-title":"N Engl J Med"},{"key":"4552_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20:309\u201325.","journal-title":"Nat Rev Drug Discov"},{"key":"4552_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41467-018-04255-z","volume":"9","author":"Q Luo","year":"2018","unstructured":"Luo Q, Lin YX, Yang PP, Wang Y, Qi GB, Qiao ZY, Li BN, Zhang K, Zhang JP, Wang L, Wang H. A self-destructive nanosweeper that captures and clears amyloid beta-peptides. Nat Commun. 2018;9:1802.","journal-title":"Nat Commun"},{"key":"4552_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuropharm.2016.04.025","volume":"108","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Chen S, Yu S, Qin J, Zhang J, Cheng Q, Ke K, Ding F. Neuroprotective effects of pyrroloquinoline quinone against rotenone injury in primary cultured midbrain neurons and in a rat model of Parkinson\u2019s disease. Neuropharmacology. 2016;108:238\u201351.","journal-title":"Neuropharmacology"},{"key":"4552_CR17","doi-asserted-by":"publisher","first-page":"102992","DOI":"10.1016\/j.arr.2025.102992","volume":"114","author":"S Ulpathakumbura","year":"2026","unstructured":"Ulpathakumbura S, Lu SK, Gunarathne R, Yang JZ, Liu J, Jin X, Zhou Q, Lu J. Comparison of anti-aging effect of PQQ (Pyrroloquinoline quinone) and NMN\/NR (Nicotinamide mononucleotide \/Nicotinamide riboside) - possible combination use. Ageing Res Rev. 2026;114:102992.","journal-title":"Ageing Res Rev"},{"key":"4552_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41401-020-0487-2","volume":"42","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Chen J, Guo H, Lu JL, Zhou J, Guo XY, Shi Y, Zhang Y, Yu S, Zhang Q, Ding F. Pyrroloquinoline quinone promotes mitochondrial biogenesis in rotenone-induced Parkinson\u2019s disease model via AMPK activation. Acta Pharmacol Sin. 2021;42:665\u201378.","journal-title":"Acta Pharmacol Sin"},{"key":"4552_CR19","doi-asserted-by":"publisher","first-page":"e2308970","DOI":"10.1002\/advs.202308970","volume":"11","author":"X Li","year":"2024","unstructured":"Li X, Sun Y, Zhou Z, Li J, Liu S, Chen L, Shi Y, Wang M, Zhu Z, Wang G, Lu Q. Deep Learning-Driven Exploration of Pyrroloquinoline Quinone Neuroprotective Activity in Alzheimer\u2019s Disease. Adv Sci (Weinh). 2024;11:e2308970.","journal-title":"Adv Sci (Weinh)"},{"key":"4552_CR20","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1039\/C8LC00246K","volume":"18","author":"Q Zhu","year":"2018","unstructured":"Zhu Q, Heon M, Zhao Z, He M. Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics. Lab Chip. 2018;18:1690\u2013703.","journal-title":"Lab Chip"},{"key":"4552_CR21","first-page":"20240039","volume":"5","author":"J Yang","year":"2025","unstructured":"Yang J, Li Y, Jiang S, Tian Y, Zhang M, Guo S, Wu P, Li J, Xu L, Li W, et al. Engineered brain-targeting exosome for reprogramming immunosuppressive microenvironment of glioblastoma. Explor (Beijing). 2025;5:20240039.","journal-title":"Explor (Beijing)"},{"key":"4552_CR22","doi-asserted-by":"publisher","first-page":"11753","DOI":"10.1021\/acsnano.3c13150","volume":"18","author":"S Jiang","year":"2024","unstructured":"Jiang S, Cai G, Yang Z, Shi H, Zeng H, Ye Q, Hu Z, Wang Z. Biomimetic Nanovesicles as a Dual Gene Delivery System for the Synergistic Gene Therapy of Alzheimer\u2019s Disease. ACS Nano. 2024;18:11753\u201368.","journal-title":"ACS Nano"},{"key":"4552_CR23","doi-asserted-by":"publisher","first-page":"21091","DOI":"10.1021\/acsnano.4c02560","volume":"18","author":"P Xiao","year":"2024","unstructured":"Xiao P, Wang H, Liu H, Yuan H, Guo C, Feng Y, Qi P, Yin T, Zhang Y, He H, et al. Milk Exosome-Liposome Hybrid Vesicles with Self-Adapting Surface Properties Overcome the Sequential Absorption Barriers for Oral Delivery of Peptides. ACS Nano. 2024;18:21091\u2013111.","journal-title":"ACS Nano"},{"key":"4552_CR24","doi-asserted-by":"publisher","first-page":"123403","DOI":"10.1016\/j.biomaterials.2025.123403","volume":"322","author":"B Du","year":"2025","unstructured":"Du B, Zou Q, Wang X, Wang H, Yang X, Wang Q, Wang K. Multi-targeted engineered hybrid exosomes as Abeta nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer\u2019s disease. Biomaterials. 2025;322:123403.","journal-title":"Biomaterials"},{"key":"4552_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/422832a","volume":"422","author":"T Kasahara","year":"2003","unstructured":"Kasahara T, Kato T. Nutritional biochemistry: A new redox-cofactor vitamin for mammals. Nature. 2003;422:832.","journal-title":"Nature"},{"key":"4552_CR26","doi-asserted-by":"publisher","first-page":"18160","DOI":"10.1021\/acsnano.3c09642","volume":"18","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Cai G, Wang Y, Guo Y, Yang Z, Wang A, Chen Y, Li X, Chen X, Hu Z, Wang Z. Microarray Chip-Based High-Throughput Screening of Neurofilament Light Chain Self-Assembling Peptide for Noninvasive Monitoring of Alzheimer\u2019s Disease. ACS Nano. 2024;18:18160\u201375.","journal-title":"ACS Nano"},{"key":"4552_CR27","doi-asserted-by":"publisher","first-page":"13283","DOI":"10.1007\/s12274-023-5921-6","volume":"16","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang L, Chen LF, Wu W, Yang ZM, Wang YZ, Wang AQ, Jiang SJ, Qin XZ, Ye ZC, et al. Glioblastoma cell-derived exosomes functionalized with peptides as efficient nanocarriers for synergistic chemotherapy of glioblastoma with improved biosafety. Nano Res. 2023;16:13283\u201393.","journal-title":"Nano Res"},{"key":"4552_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s12035-023-03591-6","volume":"61","author":"A Sarkar","year":"2024","unstructured":"Sarkar A, Singh MP. A Complex Interplay of DJ-1, LRRK2, and Nrf2 in the Regulation of Mitochondrial Function in Cypermethrin-Induced Parkinsonism. Mol Neurobiol. 2024;61:953\u201370.","journal-title":"Mol Neurobiol"},{"key":"4552_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00441-023-03806-1","volume":"393","author":"X Geng","year":"2023","unstructured":"Geng X, Zou Y, Li J, Li S, Qi R, Yu H, Zhong L. BDNF alleviates Parkinson\u2019s disease by promoting STAT3 phosphorylation and regulating neuronal autophagy. Cell Tissue Res. 2023;393:455\u201370.","journal-title":"Cell Tissue Res"},{"key":"4552_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-021-02312-4","volume":"141","author":"A Thomzig","year":"2021","unstructured":"Thomzig A, Wagenfuhr K, Pinder P, Joncic M, Schulz-Schaeffer WJ, Beekes M. Transmissible alpha-synuclein seeding activity in brain and stomach of patients with Parkinson\u2019s disease. Acta Neuropathol. 2021;141:861\u201379.","journal-title":"Acta Neuropathol"},{"key":"4552_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2024.12.056","volume":"567","author":"N Yin","year":"2025","unstructured":"Yin N, Li P, Li X, Li X, Wang Y, Yu X, Deng Y, Wang C, Yu S. Increased alpha-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson\u2019s disease. Neuroscience. 2025;567:28\u201336.","journal-title":"Neuroscience"},{"key":"4552_CR32","doi-asserted-by":"publisher","first-page":"167727","DOI":"10.1016\/j.bbadis.2025.167727","volume":"1871","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang J, Jing X, Huang K, Chen Y, Shen Q, Tao E, Lin D. Microglia toxicology in alpha-synuclein pathology. Biochim Biophys Acta Mol Basis Dis. 2025;1871:167727.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4552_CR33","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/ijms24021436","volume":"24","author":"D Lin","year":"2023","unstructured":"Lin D, Zhang H, Zhang J, Huang K, Chen Y, Jing X, Tao E. alpha-Synuclein Induces Neuroinflammation Injury through the IL6ST-AS\/STAT3\/HIF-1alpha Axis. Int J Mol Sci. 2023;24:1436.","journal-title":"Int J Mol Sci"},{"key":"4552_CR34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.neuron.2021.10.032","volume":"110","author":"I Stojkovska","year":"2022","unstructured":"Stojkovska I, Wani WY, Zunke F, Belur NR, Pavlenko EA, Mwenda N, Sharma K, Francelle L, Mazzulli JR. Rescue of alpha-synuclein aggregation in Parkinson\u2019s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking. Neuron. 2022;110:436\u2013e451411.","journal-title":"Neuron"},{"key":"4552_CR35","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1038\/s41467-024-49016-3","volume":"15","author":"X Mao","year":"2024","unstructured":"Mao X, Gu H, Kim D, Kimura Y, Wang N, Xu E, Kumbhar R, Ming X, Wang H, Chen C, et al. Aplp1 interacts with Lag3 to facilitate transmission of pathologic alpha-synuclein. Nat Commun. 2024;15:4663.","journal-title":"Nat Commun"},{"key":"4552_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","volume":"16","author":"C Peng","year":"2020","unstructured":"Peng C, Trojanowski JQ, Lee VM. Protein transmission in neurodegenerative disease. Nat Rev Neurol. 2020;16:199\u2013212.","journal-title":"Nat Rev Neurol"},{"key":"4552_CR37","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41591-024-03270-6","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T, Simuni T, Postuma RB, Pavese N, Stocchi F, et al. Sustained effect of prasinezumab on Parkinson\u2019s disease motor progression in the open-label extension of the PASADENA trial. Nat Med. 2024;30:3669\u201375.","journal-title":"Nat Med"},{"key":"4552_CR38","doi-asserted-by":"publisher","first-page":"28282","DOI":"10.1021\/jacs.4c08869","volume":"146","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiang H, Tao Y, Li J, Zeng S, Xu Q, Xiao H, Lv S, Song C, Cheng Y, et al. Inhibitor Development for alpha-Synuclein Fibril\u2019s Disordered Region to Alleviate Parkinson\u2019s Disease Pathology. J Am Chem Soc. 2024;146:28282\u201395.","journal-title":"J Am Chem Soc"},{"key":"4552_CR39","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.1038\/s41467-025-62755-1","volume":"16","author":"S Zeng","year":"2025","unstructured":"Zeng S, Xiong X, Long H, Xu Q, Yu Y, Sun B, Liu C, Wang Z, Xu W, Zhang S, Li D. Design of Ig-like binders targeting alpha-synuclein fibril for mitigating its pathological activities. Nat Commun. 2025;16:7368.","journal-title":"Nat Commun"},{"key":"4552_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/antiox9070570","volume":"9","author":"HA Park","year":"2020","unstructured":"Park HA, Ellis AC. Dietary Antioxidants and Parkinson\u2019s Disease. Antioxid (Basel). 2020;9:570.","journal-title":"Antioxid (Basel)"},{"key":"4552_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis. 2013;3:461\u201391.","journal-title":"J Parkinsons Dis"},{"key":"4552_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/antiox12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti S, Bisaglia M. Oxidative Stress and Neuroinflammation in Parkinson\u2019s Disease: The Role of Dopamine Oxidation Products. Antioxid (Basel). 2023;12:955.","journal-title":"Antioxid (Basel)"},{"key":"4552_CR43","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12974-025-03455-x","volume":"22","author":"H Jia","year":"2025","unstructured":"Jia H, Liu M, Jiang H, Qiao Z, Ren K, Du X, Chen X, Jiao Q, Che F. Repurposing of epalrestat for neuroprotection in parkinson\u2019s disease via activation of the KEAP1\/Nrf2 pathway. J Neuroinflammation. 2025;22:125.","journal-title":"J Neuroinflammation"},{"key":"4552_CR44","doi-asserted-by":"publisher","first-page":"101027","DOI":"10.1016\/j.nantod.2020.101027","volume":"36","author":"YQ Liu","year":"2021","unstructured":"Liu YQ, Mao Y, Xu E, Jia H, Zhang S, Dawson VL, Dawson TM, Li YM, Zheng Z, He W, Mao X. Nanozyme scavenging ROS for prevention of pathologic \u03b1-synuclein transmission in Parkinson\u2019s disease. Nano Today. 2021;36:101027.","journal-title":"Nano Today"},{"key":"4552_CR45","doi-asserted-by":"publisher","first-page":"e00279","DOI":"10.1016\/j.heliyon.2017.e00279","volume":"3","author":"D Sawmiller","year":"2017","unstructured":"Sawmiller D, Li S, Mori T, Habib A, Rongo D, Delic V, Bradshaw PC, Shytle RD, Sanberg C, Bickford P, Tan J. Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer\u2019s disease. Heliyon. 2017;3:e00279.","journal-title":"Heliyon"},{"key":"4552_CR46","doi-asserted-by":"publisher","first-page":"e70138","DOI":"10.1111\/acel.70138","volume":"24","author":"B Jiang","year":"2025","unstructured":"Jiang B, Zhang H, Xu Q, Jiang Z, He R, Fu Q, Sun Y. Pyrroloquinoline Quinone Is an Effective Senomorphic Agent to Target the Pro-Inflammatory Phenotype of Senescent Cells. Aging Cell. 2025;24:e70138.","journal-title":"Aging Cell"},{"key":"4552_CR47","doi-asserted-by":"publisher","first-page":"102156","DOI":"10.1016\/j.pupt.2022.102156","volume":"76","author":"M Shafiq","year":"2022","unstructured":"Shafiq M, Lone ZR, Bharati P, Mahapatra S, Rai P, Khandelwal N, Gaikwad AN, Jagavelu K, Hanif K. Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions. Pulm Pharmacol Ther. 2022;76:102156.","journal-title":"Pulm Pharmacol Ther"},{"key":"4552_CR48","doi-asserted-by":"publisher","first-page":"100889","DOI":"10.1016\/j.crfs.2024.100889","volume":"9","author":"T Yan","year":"2024","unstructured":"Yan T, Nisar MF, Hu X, Chang J, Wang Y, Wu Y, Liu Z, Cai Y, Jia J, Xiao Y, Wan C. Pyrroloquinoline Quinone (PQQ): Its impact on human health and potential benefits: PQQ: Human health impacts and benefits. Curr Res Food Sci. 2024;9:100889.","journal-title":"Curr Res Food Sci"},{"key":"4552_CR49","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.jnutbio.2013.07.008","volume":"24","author":"CB Harris","year":"2013","unstructured":"Harris CB, Chowanadisai W, Mishchuk DO, Satre MA, Slupsky CM, Rucker RB. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. J Nutr Biochem. 2013;24:2076\u201384.","journal-title":"J Nutr Biochem"},{"key":"4552_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/09168451.2015.1062715","volume":"80","author":"M Akagawa","year":"2016","unstructured":"Akagawa M, Nakano M, Ikemoto K. Recent progress in studies on the health benefits of pyrroloquinoline quinone. Biosci Biotechnol Biochem. 2016;80:13\u201322.","journal-title":"Biosci Biotechnol Biochem"},{"key":"4552_CR51","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41586-025-09244-z","volume":"644","author":"K Hou","year":"2025","unstructured":"Hou K, Ge P, Sawaya MR, Lutter L, Dolinsky JL, Yang Y, Jiang YX, Boyer DR, Cheng X, Pi J, et al. How short peptides disassemble tau fibrils in Alzheimer\u2019s disease. Nature. 2025;644:1020\u20137.","journal-title":"Nature"},{"key":"4552_CR52","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.7150\/thno.56541","volume":"11","author":"HL Wan","year":"2021","unstructured":"Wan HL, Hong XY, Zhao ZH, Li T, Zhang BG, Liu Q, Wang Q, Zhao S, Wang JZ, Shen XF, Liu GP. STAT3 ameliorates cognitive deficits via regulation of NMDAR expression in an Alzheimer\u2019s disease animal model. Theranostics. 2021;11:5511\u201324.","journal-title":"Theranostics"},{"key":"4552_CR53","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3390\/ijms24010864","volume":"24","author":"M Rusek","year":"2023","unstructured":"Rusek M, Smith J, El-Khatib K, Aikins K, Czuczwar SJ, Pluta R. The Role of the JAK\/STAT Signaling Pathway in the Pathogenesis of Alzheimer\u2019s Disease: New Potential Treatment Target. Int J Mol Sci. 2023;24:864.","journal-title":"Int J Mol Sci"},{"key":"4552_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3233\/JAD-160887","volume":"55","author":"N Iwahara","year":"2017","unstructured":"Iwahara N, Hisahara S, Kawamata J, Matsumura A, Yokokawa K, Saito T, Fujikura M, Manabe T, Suzuki H, Matsushita T, et al. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe\/PS1dE9 Mice. J Alzheimers Dis. 2017;55:1235\u201347.","journal-title":"J Alzheimers Dis"},{"key":"4552_CR55","first-page":"51","volume":"8","author":"C Porro","year":"2019","unstructured":"Porro C, Cianciulli A, Trotta T, Lofrumento DD, Panaro MA. Curcumin Regulates Anti-Inflammatory Responses by JAK\/STAT\/SOCS Signaling Pathway in BV-2 Microglial Cells. Biology (Basel). 2019;8:51.","journal-title":"Biology (Basel)"},{"key":"4552_CR56","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-pharmtox-062124-043519","volume":"66","author":"O Hoffman","year":"2026","unstructured":"Hoffman O, Varvel NH, Roopra AS, Dingledine R. Neuroinflammation and Disease: Pathways and Opportunities. Annu Rev Pharmacol Toxicol. 2026;66:541\u201363.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4552_CR57","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.3390\/ijms21124407","volume":"21","author":"WA Banks","year":"2020","unstructured":"Banks WA, Sharma P, Bullock KM, Hansen KM, Ludwig N, Whiteside TL. Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. Int J Mol Sci. 2020;21:4407.","journal-title":"Int J Mol Sci"},{"key":"4552_CR58","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/ph16040571","volume":"16","author":"M Abdelsalam","year":"2023","unstructured":"Abdelsalam M, Ahmed M, Osaid Z, Hamoudi R, Harati R. Insights into Exosome Transport through the Blood-Brain Barrier and the Potential Therapeutical Applications in Brain Diseases. Pharmaceuticals (Basel). 2023;16:571.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4552_CR59","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12951-025-03352-8","volume":"23","author":"S Mehdizadeh","year":"2025","unstructured":"Mehdizadeh S, Mamaghani M, Hassanikia S, Pilehvar Y, Ertas YN. Exosome-powered neuropharmaceutics: unlocking the blood-brain barrier for next-gen therapies. J Nanobiotechnol. 2025;23:329.","journal-title":"J Nanobiotechnol"},{"key":"4552_CR60","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1021\/acsnano.2c10219","volume":"17","author":"J Cui","year":"2023","unstructured":"Cui J, Wang X, Li J, Zhu A, Du Y, Zeng W, Guo Y, Di L, Wang R. Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma. ACS Nano. 2023;17:1464\u201384.","journal-title":"ACS Nano"},{"key":"4552_CR61","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.2147\/IJN.S454438","volume":"19","author":"XM Hu","year":"2024","unstructured":"Hu XM, Wang CC, Xiao Y, Liu Y, Huang HR, Jiang P, Wang YK, Lin YJ, Li LC, Qi ZQ. Non-Clinical Safety Evaluation of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells in Cynomolgus Monkeys. Int J Nanomed. 2024;19:4923\u201339.","journal-title":"Int J Nanomed"},{"key":"4552_CR62","doi-asserted-by":"publisher","first-page":"e2403199","DOI":"10.1002\/adma.202403199","volume":"36","author":"Y Xia","year":"2024","unstructured":"Xia Y, Zhang J, Liu G, Wolfram J. Immunogenicity of Extracellular Vesicles. Adv Mater. 2024;36:e2403199.","journal-title":"Adv Mater"},{"key":"4552_CR63","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.vesic.2024.100052","volume":"4","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang L, Yu X, Mao W, Wan Y. Ultrasonication outperforms electroporation for extracellular vesicle cargo depletion. Extracell Vesicle. 2024;4:100052.","journal-title":"Extracell Vesicle"},{"key":"4552_CR64","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1038\/s41467-019-13564-w","volume":"10","author":"T Strohaker","year":"2019","unstructured":"Strohaker T, Jung BC, Liou SH, Fernandez CO, Riedel D, Becker S, Halliday GM, Bennati M, Kim WS, Lee SJ, Zweckstetter M. Structural heterogeneity of alpha-synuclein fibrils amplified from patient brain extracts. Nat Commun. 2019;10:5535.","journal-title":"Nat Commun"},{"key":"4552_CR65","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12974-020-01888-0","volume":"17","author":"M Iba","year":"2020","unstructured":"Iba M, Kim C, Sallin M, Kwon S, Verma A, Overk C, Rissman RA, Sen R, Sen JM, Masliah E. Neuroinflammation is associated with infiltration of T cells in Lewy body disease and alpha-synuclein transgenic models. J Neuroinflammation. 2020;17:214.","journal-title":"J Neuroinflammation"},{"key":"4552_CR66","doi-asserted-by":"publisher","first-page":"014104","DOI":"10.1088\/1748-605X\/ac4089","volume":"17","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, Wang Q, Zhu Z, Zheng W, Ma S, Hao Y, Yang L, Cheng G. Cell-derived extracellular matrix enhanced by collagen-binding domain-decorated exosomes to promote neural stem cells neurogenesis. Biomed Mater. 2021;17:014104.","journal-title":"Biomed Mater"},{"key":"4552_CR67","first-page":"196","volume":"29","author":"Y Wu","year":"2023","unstructured":"Wu Y, Huang X, Tan Z, Zang J, Peng M, He N, Zhang T, Mai H, Xu A, Lu D. FUS-mediated HypEVs: Neuroprotective effects against ischemic stroke. Bioact Mater. 2023;29:196\u2013213.","journal-title":"Bioact Mater"},{"key":"4552_CR68","doi-asserted-by":"publisher","first-page":"32013","DOI":"10.1021\/acsami.5c05809","volume":"17","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhan M, Sun H, Zou Y, Laurent R, Mignani S, Majoral JP, Cao X, Shen M, Shi X. Mesenchymal Stem-Cell-Derived Exosomes Loaded with Phosphorus Dendrimers and Quercetin Treat Parkinson\u2019s Disease by Modulating Inflammatory Immune Microenvironment. ACS Appl Mater Interfaces. 2025;17:32013\u201327.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4552_CR69","doi-asserted-by":"publisher","first-page":"eadl3406","DOI":"10.1126\/sciadv.adl3406","volume":"10","author":"F Aliakbari","year":"2024","unstructured":"Aliakbari F, Marzookian K, Parsafar S, Hourfar H, Nayeri Z, Fattahi A, Raeiji M, Boroujeni NN, Otzen DE, Morshedi D. The impact of hUC MSC-derived exosome-nanoliposome hybrids on alpha-synuclein fibrillation and neurotoxicity. Sci Adv. 2024;10:eadl3406.","journal-title":"Sci Adv"},{"key":"4552_CR70","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley LA, Luk KC, Lee VM. Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates. Nat Protoc. 2014;9:2135\u201346.","journal-title":"Nat Protoc"},{"key":"4552_CR71","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1021\/cr800323s","volume":"109","author":"A Isidro-Llobet","year":"2009","unstructured":"Isidro-Llobet A, Alvarez M, Albericio F. Amino acid-protecting groups. Chem Rev. 2009;109:2455\u2013504.","journal-title":"Chem Rev"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04552-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04552-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:02:32Z","timestamp":1784548952000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04552-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4552"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04552-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"679"}}